Epithelial tissue — the cells lining your skin and organs — maintains itself through a process that looks like distributed competitive testing. As tissue grows crowded, physical pressure on cells opens ion channels that let sodium leak in. Healthy cells spend energy to pump the sodium back out, restoring their membrane voltage. Cells that can't maintain voltage fail the test.
The failure cascade is precise. When a cell's voltage collapses, voltage-gated potassium channels open. Potassium rushes out, and water follows osmotically. The cell shrinks. At exactly 17% volume loss — not 10%, not 25%, but a surprisingly specific threshold — the cell triggers a biochemical cascade that activates motor proteins. The surrounding tissue physically ejects it.
Jody Rosenblatt's team at King's College London and the Francis Crick Institute published these findings in Nature. The mechanism is beautiful in its logic: the tissue doesn't have a central quality control system that inspects individual cells. Instead, it applies uniform mechanical stress (crowding) and lets each cell's energy budget determine whether it passes. The test is the same for everyone. The outcome depends on internal resources.
No cell votes to eject its neighbor. Each cell simply responds to the same pressure with whatever capacity it has. The healthy cells pump sodium, maintain voltage, keep their volume. The weak cells can't pump, lose voltage, lose water, shrink past 17%, and are removed. The “decision” to extrude a cell emerges from distributed electrical competition without any cell knowing the outcome in advance.
The failure modes illuminate the design. When extrusion fails — when cells can no longer communicate their electrical distress — uncontrolled growth results. Rosenblatt's team suggests this may be a mechanism for certain cancers: cells that should be ejected surviving because the bioelectric signaling broke down. In the other direction, excessive extrusion compromises tissue integrity. Asthma may involve “overzealous culling” — the threshold set too aggressively, ejecting cells that could have recovered.
Cancer and asthma as opposite failure modes of the same system is a striking framing. One is too little extrusion (cells that should leave don't). The other is too much (cells that should stay are ejected). The healthy state is a calibrated balance between retention and removal, maintained not by a master regulator but by the biophysics of ion transport.
The 17% threshold is the detail that elevates this from interesting mechanism to structural insight. A threshold implies a switch — below 17%, the cell is pressured but recoverable; above 17%, it is committed to ejection. The transition is not gradual. There is a volume at which the cell goes from “struggling” to “condemned,” and that volume is precise enough to measure. Somewhere in the molecular machinery connecting cell volume to motor protein activation, there is a sensor calibrated to that specific degree of shrinkage.
This is governance without government. The tissue maintains quality, removes defectives, and balances growth — all through physics. Ion gradients, osmotic pressure, mechanical stress, and a volume threshold. No signaling network coordinates the decision. No transcription factor specifies which cells live and which are expelled. The information is in the voltage, and the voltage is in the energy budget, and the energy budget reflects the cell's health. The entire quality-control system runs on electricity and water.